These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9431309)

  • 1. Quality and liability issues with the Papanicolaou smear.
    Sirota RL
    Arch Pathol Lab Med; 1997 Dec; 121(12):1237-8. PubMed ID: 9431309
    [No Abstract]   [Full Text] [Related]  

  • 2. HPV: from the cervical smear to the research bench to the court room.
    Atkins K
    Clin Leadersh Manag Rev; 2003; 17(6):341-5. PubMed ID: 14692078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liability issues with the Papanicolaou smear: the view of a hospital administrator at Newport Hospital, Newport, Rhode Island.
    Sampson AJ
    Arch Pathol Lab Med; 1997 Mar; 121(3):241-5. PubMed ID: 9111108
    [No Abstract]   [Full Text] [Related]  

  • 4. The gynecologist's perspective of liability and quality issues with the Papanicolaou smear.
    Greer BE
    Arch Pathol Lab Med; 1997 Mar; 121(3):246-9. PubMed ID: 9111109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reducing the error rate in Papanicolaou smears. One laboratory's experience with the PAPNET system.
    Koss LG
    Physician Assist; 1994 Dec; 18(12):48-52. PubMed ID: 10139375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liability issues with the Papanicolaou smear: general legal background.
    Kline TJ
    Arch Pathol Lab Med; 1997 Mar; 121(3):250-2. PubMed ID: 9111110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [HPV test for quality control of gynecologic cytological tests].
    Wilander E; Wikström I
    Lakartidningen; 2008 Nov 26-Dec 9; 105(48-49):3560, 3564. PubMed ID: 19133586
    [No Abstract]   [Full Text] [Related]  

  • 8. Quality and liability issues with the Papanicolaou smear: the role of professional organizations in reform initiatives.
    Stanley MW
    Arch Pathol Lab Med; 1997 Mar; 121(3):321-6. PubMed ID: 9111127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. College of American Pathologists Conference XXX on quality and liability issues with the Papanicolaou smear: introduction.
    Austin RM
    Arch Pathol Lab Med; 1997 Mar; 121(3):227-8. PubMed ID: 9111105
    [No Abstract]   [Full Text] [Related]  

  • 10. Errors in cervical smears: minimizing the risk of medicolegal consequences.
    Greening SE
    Monogr Pathol; 1997; (39):16-39. PubMed ID: 9249818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liability issues with the Papanicolaou smear: the expert witness database.
    Wood WS
    Arch Pathol Lab Med; 1997 Mar; 121(3):335-40. PubMed ID: 9111130
    [No Abstract]   [Full Text] [Related]  

  • 12. Liability issues with the Papanicolaou smear: a defense lawyer's perspective.
    Varner CD
    Arch Pathol Lab Med; 1997 Mar; 121(3):315-20. PubMed ID: 9111126
    [No Abstract]   [Full Text] [Related]  

  • 13. Quality control in cytopathology applied to screening for cervical carcinoma.
    Marsan C
    Pol J Pathol; 1995; 46(4):245-8. PubMed ID: 8713292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality control in cytologic screening.
    Cecchini S; Grazzini G; Bonardi R; Ciatto S
    Acta Cytol; 1993; 37(3):436. PubMed ID: 8498145
    [No Abstract]   [Full Text] [Related]  

  • 15. Papanicolaou smear.
    Lipa M; Geddie W; Fletcher WA; Thompson DW; Turner-Smith L; Wood DE
    CMAJ; 1994 Jun; 150(11):1756-8. PubMed ID: 8054023
    [No Abstract]   [Full Text] [Related]  

  • 16. Quality assurance in cervical cytopathology.
    Light AM
    Cytopathology; 1997 Aug; 8(4):290-2. PubMed ID: 9252748
    [No Abstract]   [Full Text] [Related]  

  • 17. [A reply on cervix cancer screening: cervical cytological test doesn't fulfil the requirements of a good screening test].
    Bistoletti P
    Lakartidningen; 2000 Sep; 97(37):4042. PubMed ID: 11036367
    [No Abstract]   [Full Text] [Related]  

  • 18. [An operative model: verification of the quality of the screening Pap test ].
    Montanari GR; Arnaud S; Berardengo E; Campione D; Cozzani C; Parisio F; Viberti L; Ghiringhello B
    Pathologica; 2001 Oct; 93(5):609-10. PubMed ID: 11725370
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the occasion of the 65th birthday of the cervical smear: added value of population studies for cervical cancer remains unclear].
    Giard RW
    Ned Tijdschr Geneeskd; 2007 Jun; 151(23):1268-71. PubMed ID: 17624154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liability issues with the Papanicolaou smear: an insurance industry perspective.
    Scott MD
    Arch Pathol Lab Med; 1997 Mar; 121(3):239-40. PubMed ID: 9111107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.